Description: Edrecolomab is a mouse/murine-derived IgG2A monoclonal antibody targeting the cell-surface glycoprotein EpCAM, which is expressed on epithelial tissues and on various carcinomas. Preliminary studies had shown promise of a possible use in patients with stage III colorectal carcinoma.

纯度：≥98%

CAS：156586-89-9